Connection

Bryan Toole to Up-Regulation

This is a "connection" page, showing publications Bryan Toole has written about Up-Regulation.
Connection Strength

0.249
  1. Regulation of invadopodia formation and activity by CD147. J Cell Sci. 2012 Feb 01; 125(Pt 3):777-88.
    View in: PubMed
    Score: 0.081
  2. KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction. Int J Cancer. 2012 Aug 15; 131(4):834-43.
    View in: PubMed
    Score: 0.079
  3. Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients. Cancer Lett. 2015 Jul 01; 362(2):158-66.
    View in: PubMed
    Score: 0.025
  4. Synthetic emmprin peptides inhibit tumor cell-fibroblast interaction-stimulated upregulation of MMP-2 and tumor cell invasion. Int J Oncol. 2011 Sep; 39(3):657-64.
    View in: PubMed
    Score: 0.019
  5. Aggrecan expression is substantially and abnormally upregulated in Hutchinson-Gilford Progeria Syndrome dermal fibroblasts. Mech Ageing Dev. 2006 Aug; 127(8):660-9.
    View in: PubMed
    Score: 0.014
  6. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation. 2006 Feb 14; 113(6):834-41.
    View in: PubMed
    Score: 0.013
  7. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer. 2000 Oct 01; 88(1):21-7.
    View in: PubMed
    Score: 0.009
  8. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett. 2000 Sep 01; 157(2):177-84.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.